MAPK8 and adenomyosis: Consistently, perioperative administration of the JNK inhibitor SP600125 reduced the incidence by one-third, in conjunction with reduced myometrial infiltration of the adenomyosis induced by EMID and alleviation of adenomyosis-associated hyperalgesia.